Medicare Enrolled
Dr. Melissa Dillmon, MD
Hematology & Oncology · Rome, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dillmon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dillmon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dillmon
Dr. Melissa Dillmon is a hematology & oncology specialist in Rome, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dillmon performed 82,815 Medicare services across 2,998 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dillmon received a total of $10,865 from 37 pharmaceutical and/or device companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dillmon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in GA
$10,865 industry payments
Medicare Practice Summary
Medicare Utilization ↗82,815
Medicare services
Top 10% in GA for hematology & oncology
2,998
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,359 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 25,140 | $18 | $50 |
| Pembrolizumab injection (Keytruda) | 24,400 | $43 | $115 |
| Anti-nausea injection (aprepitant) | 6,630 | $1 | $5 |
| Paclitaxel chemotherapy injection | 4,914 | $0 | $1 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
3,920 | $34 | $100 |
| Trastuzumab biosimilar injection, 10 mg An injection of trastuzumab-qyyp, a biosimilar medication, administered in a 10 mg dose. |
3,034 | $21 | $135 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,725 | $0 | $8 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,060 | $1 | $76 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,509 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,362 | $7 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,001 | $10 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
563 | $83 | $158 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
489 | $10 | $52 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
481 | $88 | $450 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
468 | $68 | $570 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
431 | $2 | $84 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
385 | $2 | $230 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
349 | $20 | $80 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
335 | $11 | $55 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
238 | $60 | $108 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
173 | $42 | $250 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
172 | $16 | $70 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
151 | $6 | $30 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
149 | $1 | $14 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
149 | $7 | $20 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
135 | $9 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
102 | $44 | $155 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
89 | $14 | $55 |
| Iron level test | 88 | $6 | $30 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
88 | $8 | $45 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
84 | $51 | $250 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 73 | $20 | $100 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
72 | $13 | $85 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
68 | $20 | $110 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
66 | $132 | $212 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
63 | $15 | $65 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
60 | $15 | $50 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
46 | $23 | $120 |
| New patient office visit, complex (60-74 min) | 46 | $157 | $302 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
44 | $1 | $8 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
42 | $17 | $100 |
| PSA test (prostate cancer screening) | 42 | $18 | $85 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
42 | $40 | $215 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
39 | $1 | $25 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
35 | $179 | $650 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
33 | $15 | $35 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
30 | $14 | $75 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $89 | $168 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
23 | $14 | $50 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $9 | $40 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
20 | $6 | $25 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
20 | $1 | $30 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
17 | $15 | $45 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
17 | $17 | $90 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
16 | $3 | $25 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
15 | $8 | $45 |
| Complete x-ray of body bones An x-ray imaging procedure that captures images of the entire skeletal system. |
13 | $44 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $116 | $242 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.3% high complexity
86.5% medium
7.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,865
Total received (2018-2024)
Avg $1,552/year across 7 years
Top 28% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
108
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,611 (42.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,461 (31.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,793 (25.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$572
2023
$2,963
2022
$2,702
2021
$2,076
2020
$1,913
2019
$373
2018
$264
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$223
AstraZeneca Pharmaceuticals LP
$141
PFIZER INC.
$63
ABBVIE INC.
$29
Novartis Pharmaceuticals Corporation
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Astellas Pharma US Inc
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
INTUITIVE SURGICAL, INC.
$16
Top 3 companies account for 74.5% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$2,755
BeiGene USA, Inc.
$2,074
Seagen Inc.
$1,806
McKesson Specialty Care Distribution, LLC
$1,044
AstraZeneca Pharmaceuticals LP
$476
Janssen Biotech, Inc.
$279
COMSORT, Inc
$250
GENZYME CORPORATION
$223
Taiho Oncology, Inc.
$169
Foundation Medicine, Inc.
$169
Puma Biotechnology, Inc.
$169
Novartis Pharmaceuticals Corporation
$150
Mirati Therapeutics, Inc.
$125
Daiichi Sankyo Inc.
$125
Incyte Corporation
$125
Takeda Pharmaceuticals U.S.A., Inc.
$124
Seattle Genetics, Inc.
$87
Gilead Sciences, Inc.
$85
Exelixis Inc.
$85
Astellas Pharma US Inc
$80
Amgen Inc.
$69
Genentech USA, Inc.
$52
Eisai Inc.
$45
US Oncology Corporate, Inc.
$39
Janssen Scientific Affairs, LLC
$30
ABBVIE INC.
$29
Agios Pharmaceuticals, Inc.
$29
Sobi, Inc
$24
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Stemline Therapeutics Inc.
$19
Karyopharm Therapeutics Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Merck Sharp & Dohme Corporation
$18
Regeneron Healthcare Solutions, Inc.
$17
INTUITIVE SURGICAL, INC.
$16
Pharmacyclics LLC, An AbbVie Company
$13
ARRAY BIOPHARMA INC
$6
Top 3 companies account for 61.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · BRAFTOVI · BRUKINSA · CAPRELSA · DARZALEX · DOPTELET · Da Vinci Surgical System · ELREXFIO · Enhertu · Erleada · FOUNDATIONONE · FOUNDATIONONE CDX · GAZYVA · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · INQOVI · KANJINTI · KEYTRUDA · KRAZATI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MONJUVI · MVASI · NERLYNX · NINLARO · Nubeqa · Orserdu · PADCEV · PIQRAY · PLUVICTO · Padcev · RYBREVANT · SANDOSTATIN · SARCLISA · SCEMBLIX · TAGRISSO · TECVAYLI · TIBSOVO · TUKYSA · Trodelvy · VENCLEXTA · XOSPATA · XPOVIO · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (42%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
6
Per 100K population
6.1
County median income
$62,540
Nearest hospital
ADVENTHEALTH REDMOND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dillmon is a mixed practice specialist, with above-average Medicare volume (top 10% in GA), with consulting-driven industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dillmon experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Dillmon performed 25,140 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dillmon receive payments from pharmaceutical companies?
Yes. Dr. Dillmon received a total of $10,865 from 37 companies across 108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dillmon's costs compare to other hematology & oncology specialists in Rome?
Dr. Dillmon's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dillmon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Rome
Browse hematology & oncology specialists in Rome ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology